Advanced search×

Searching for metachronous tumours in patients with head and neck cancer: the ideal protocol!

Patrick J Bradley and Paula T Bradley

Curr Opin Otolaryngol Head Neck Surg 18(2):124-33 (2010) PMID 20234214

As treatment changes in the management of head and neck cancer, patients are reportedly living longer; therefore, their death may be due to comorbidity, metastatic disease or the development of a metachronous second primary tumour (MSPT). This review describes recent developments in the identification of MSPTs of head and neck cancer, oesophagus and lung, and suggests/recommends an 'ideal surveillance protocol'.

DOI: 10.1097/MOO.0b013e3283374ccf
Version: za2963e q8za9 q8zb1 q8zcc q8zda q8zef q8zf7 q8zg1

Similar articles you may find interesting…

  1. Clinical applications of positron emission tomography-computed tomography in oncology.
    R R Kumar, D D Halanaik, and A A Malhotra

    Audio, Transactions of the IRE Profession... 47(2):100-19 (2010) PMID 20448371

    Positron emission computed tomography (PET) is a functional diagnostic imaging technique, which can accurately measure in vivo distribution of a variety of radiopharmaceuticals. The ability of PET to study various biological processes (glucose, amino acid, phospholipids, receptors etc.) opens up new...
  2. Role of positron emission tomography (PET) in head and neck cancer
    M M Duet, F F Hugonnet, and M M Faraggi

    Eur Ann Otorhinolaryngol Head Neck Dis 127(1):6 (2010) PMID 20822756

    F-18 fluorodeoxyglucose positron emission tomography is now part of the initial stage III and IV cancer work-up and each time that metastasis or the presence of a second cancer is suspected that may contraindicate major surgery. Similarly, this exam should be undertaken when the conventional work-up...
  3. PET/CT in head and neck cancer: an update.
    Roland R Hustinx and Giovanni G Lucignani

    Audio, Transactions of the IRE Profession... 37(3):645-51 (2010) PMID 20187296